u/Ad_Weekly — thesis ledger

Window	Theses	Resolved	Wins	Win rate	Avg return	Median return
1d	1	1	0	0%	-5.3%	-5.3%
3d	1	1	0	0%	-4.5%	-4.5%
1w	1	1	0	0%	-14.2%	-14.2%
1m	1	1	1	100%	+19.3%	+19.3%
3m	1	1	1	100%	+22.8%	+22.8%
6m	1	1	1	100%	+10.2%	+10.2%
1y	0	0	0	—	—	—

Window

Theses

Resolved

Wins

Win rate

Avg return

Median return

-5.3%

-4.5%

-14.2%

100%

+19.3%

100%

+22.8%

100%

+10.2%

—

Thesis history

$IBRXr/pennystocksDDbullish

u/Ad_Weekly · 263d agono track record yet

$IBRX (ImmunityBio) can become the next short-term rocket/long-term investment

ImmunityBio's Anktiva, an IL-15 immunotherapy developed by billionaire oncologist Patrick Soon-Shiong, has clinically proven efficacy in bladder cancer and ongoing success in glioblastoma trials. Short-term catalyst: 127M shorted shares (38.8% of float) requiring cover within days; long-term upside driven by FDA resubmission, EMA approval expansion, and Q4 earnings report with target prices of $11-$24.

At post $6.93Now $8.29+19.6% since postedas of Oct 30, 4:45 PM ET

1d-5.3%

3d-4.5%

1w-14.2%

1m+19.3%

3m+22.8%

6m+10.2%

1y—

original post →

End of results.